These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 6303393)

  • 21. Importance of the 10-13 region of glucagon for its receptor interactions and activation of adenylate cyclase.
    Krstenansky JL; Trivedi D; Hruby VJ
    Biochemistry; 1986 Jul; 25(13):3833-9. PubMed ID: 3017406
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of the glucagon receptor in rat liver membranes by photoaffinity crosslinking.
    Johnson GL; MacAndrew VI; Pilch PF
    Proc Natl Acad Sci U S A; 1981 Feb; 78(2):875-8. PubMed ID: 6262779
    [TBL] [Abstract][Full Text] [Related]  

  • 23. New glucagon analogues with conformational restrictions and altered amphiphilicity: effects on binding, adenylate cyclase and glycogenolytic activities.
    Hruby VJ; Gysin B; Trivedi D; Johnson DG
    Life Sci; 1993; 52(10):845-55. PubMed ID: 8445980
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transfer of glucagon receptor from liver membranes to a foreign adenylate cyclase by a membrane fusion procedure.
    Schramm M
    Proc Natl Acad Sci U S A; 1979 Mar; 76(3):1174-8. PubMed ID: 220608
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differential acid stabilities of citraconylated amino groups of glucagon. Preparation of N alpha-citraconyl glucagon and evaluation of its biological properties.
    Liepnieks JJ; Epand RM
    Biochim Biophys Acta; 1982 Oct; 707(2):171-7. PubMed ID: 6291617
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthetic peptide antagonists of glucagon.
    Unson CG; Andreu D; Gurzenda EM; Merrifield RB
    Proc Natl Acad Sci U S A; 1987 Jun; 84(12):4083-7. PubMed ID: 3035568
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Topographical amino acid substitution in position 10 of glucagon leads to antagonists/partial agonists with greater binding differences.
    Azizeh BY; Shenderovich MD; Trivedi D; Li G; Sturm NS; Hruby VJ
    J Med Chem; 1996 Jun; 39(13):2449-55. PubMed ID: 8691441
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Restoration of glucagon responsiveness in spontaneously transformed rat hepatocytes (RL-PR-C) by fusion with normal progenitor cells and rat liver plasma membranes.
    Reilly TM; Blecher M
    Proc Natl Acad Sci U S A; 1981 Jan; 78(1):182-6. PubMed ID: 6264432
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Altered glucagon- and catecholamine hormone-sensitive adenylyl cyclase responsiveness in rat liver membranes induced by manipulation of dietary fatty acid intake.
    Dax EM; Partilla JS; Piñeyro MA; Gregerman RI
    Endocrinology; 1990 Nov; 127(5):2236-40. PubMed ID: 2226311
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Glucagon-stimulable adenylyl cyclase in rat liver. Effects of chronic uremia and intermittent glucagon administration.
    Dighe RR; Rojas FJ; Birnbaumer L; Garber AJ
    J Clin Invest; 1984 Apr; 73(4):1004-12. PubMed ID: 6323531
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lack of glucagon receptors in Morris hepatoma 7800.
    Mourelle M; Rojkind M
    Hepatology; 1984; 4(3):515-9. PubMed ID: 6327489
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Binding of a glucagon photoaffinity label to rat liver plasma membranes and its effect on adenylate cyclase activity before and after photolysis.
    Demoliou-Mason C; Epand RM
    Biochemistry; 1982 Apr; 21(9):1989-96. PubMed ID: 7093224
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Semisynthetic D-His1,N epsilon-acetimidoglucagon: structure-function relationships.
    Mahrenholz AM; Flanders KC; Hoosein NM; Gurd FR; Gurd RS
    Arch Biochem Biophys; 1987 Sep; 257(2):379-86. PubMed ID: 2821912
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transient complexes. A new structural model for the activation of adenylate cyclase by hormone receptors (guanine nucleotides/irradiation inactivation).
    Martin BR; Stein JM; Kennedy EL; Doberska CA; Metcalfe JC
    Biochem J; 1979 Nov; 184(2):253-60. PubMed ID: 230831
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The lipid environment of the glucagon receptor regulates adenylate cyclase activity.
    Houslay MD; Hesketh TR; Smith GA; Warren GB; Metcalfe JC
    Biochim Biophys Acta; 1976 Jun; 436(2):495-504. PubMed ID: 179599
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Importance of the C-terminal alpha-helical structure for glucagon's biological activity.
    Krstenansky JL; Zechel C; Trivedi D; Hruby VJ
    Int J Pept Protein Res; 1988 Dec; 32(6):468-75. PubMed ID: 2854536
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 3,3',5-triiodothyronine administration in vivo modulates the hormone-sensitive adenylate cyclase system of rat hepatocytes.
    Malbon CC; Greenberg ML
    J Clin Invest; 1982 Feb; 69(2):414-26. PubMed ID: 6276441
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Glucagon-stimulable adenylyl cyclase in rat liver. The impact of streptozotocin-induced diabetes mellitus.
    Dighe RR; Rojas FJ; Birnbaumer L; Garber AJ
    J Clin Invest; 1984 Apr; 73(4):1013-23. PubMed ID: 6323532
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of phenylalanine at position 6 in glucagon's mechanism of biological action: multiple replacement analogues of glucagon.
    Azizeh BY; Ahn JM; Caspari R; Shenderovich MD; Trivedi D; Hruby VJ
    J Med Chem; 1997 Aug; 40(16):2555-62. PubMed ID: 9258362
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Influence of the mouse major histocompatibility complex, H-2, on liver adenylate cyclase activity and on glucagon binding to liver cell membranes.
    Lafuse W; Edidin M
    Biochemistry; 1980 Jan; 19(1):49-54. PubMed ID: 6243475
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.